Clinical Trial Update: Prazosin for Alcohol Dependence and Posttraumatic Stress Disorder [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating prazosin for alcohol dependence and posttraumatic stress disorder has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder
• Posttraumatic Stress Disorder

Drugs mentioned

• Prazosin (prazosin)

Snippet

Sponsor: Seattle Institute for Biomedical and Clinical Research | Conditions: Alcohol Abuse, Posttraumatic Stress Disorder | Phase 2 | Status: COMPLETED | Results posted: 2020-08-25